ClinicalTrials.Veeva

Menu

Prospective Assessment in Newborns for Diabetes Autoimmunity (PANDA)

Augusta University logo

Augusta University

Status

Completed

Conditions

Type 1 Diabetes
Autoimmunity

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00649246
U01DK063865 (U.S. NIH Grant/Contract)
DK63865 - PANDA

Details and patient eligibility

About

This is an observational study designed to help researchers understand the genetics and pathogenesis of type 1 diabetes, and to identify biomarkers for disease and disease complication prediction.

Full description

This study is designed to identify people who are at risk for developing type 1 diabetes, based on their genetics, family history and autoimmunity status, and to understand the role genetics plays in the development of the complications associated with type 1 diabetes in patients already affected by type 1 diabetes.

Enrollment

25,055 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: all are welcome -

Exclusion Criteria:

Trial design

25,055 participants in 3 patient groups

1
Description:
controls: healthy individuals with no family history of type 1 diabetes
2
Description:
high-risk: Subjects with islet autoantibodies or high-risk diabetes genes
3
Description:
type 1 diabetes: subjects with type 1 diabetes

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems